D.E. Shaw & Co
VBIV

D.E. Shaw & Co’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

D.E. Shaw & Co’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-731
Closed -$8.58K – 5044
2022
Q4 		$8.58K Sell
731
-900
-55% -$15.9K ﹤0.01% 4624
2022
Q3 		$35K Buy
+1,631
New +$44K ﹤0.01% 4735
2020
Q1 		– Sell
-723
Closed -$30K – 4386
2019
Q4 		$30K Sell
723
-1,442
-67% -$31.6K ﹤0.01% 3911
2019
Q3 		$31K Buy
+2,165
New +$45.3K ﹤0.01% 3745

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return